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INTRODUCTION
The laboratory and especially Haematological
manifestations and complications of viral infections
have been described in several studies.
Cytomegalovirus remains one of the most
pathogenic of the herpes viruses with a
correspondingly high morbidity and mortality
especially among immunocompromised
hosts. Studies have demonstrated a high
prevalence of cytomegalovirus infection among
various selected groups, including blood donors.
Many authors have documented a range of
haema to log ica l de rangemen ts in acute






inclusion disease. It has been observed by Horwit
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et al that thrombocytopaenia, atypical lymphocytosis
and variable cytopaenias are among the commonest
haematological complications of cytomegalovirus
induced infectious mononucleosis. While noting
that screening for CMV is not yet a routine
predonation test in many countries, cytomegalovirus
antibody seropositive individuals are commonly
accepted for blood donation in other countries where
CMV screening is a component of pre donation
algorithm. The authors are not aware of any study on
the haematological profile of cytomegalovirus
antibody seropositive persons. The objective of this
study is to determine any abnormal haematological
derangements that may be attributable to
cytomegalovirus infection. This is with a view to
ascertaining the safety and fitness of seropositive
individuals for routine blood donation since abnormal
haematologic profile can constitute a donor hazard.
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Various kinds of Haematological abnormalities and alterations have been known to occur in a
number of viral infections. These alterations define the pathology of the infection, serve as tools for diagnosis,
and assist in treatment and prognostication. But much more importantly, such alterations may constitute a
hazard and make an individual unfit for blood donation.
Given the high frequency of haematological alterations and complications associated with many viral
infections and coupled with the observation that cytomegalovirus antibody positive persons are accepted for
routine blood donation in many countries, this paper aims to evaluate the haematological profile of
cytomegalovirus antibody positive prospective donors in Jos. This is with a view to recognizing and
characterizing any associated abnormal haematological changes. It is also hoped that such data will assist in
ascertaining the safety and fitness of seropositive persons for blood donation.
Atotal of 200 prospective blood donors were recruited into the study. Screening for CMV antibodies
was done using ELISA kit, manufactured by DIALAB, Austria. ( ). Complete blood count
(PCV: Packed cell volume, WBC: White cell count-total and differential counts, and platelet counts) was done
on all donors using automated coulter machine.
Although the mean PCV value was higher in the CMV positive (38.04) than in the CMV negative
donors (37.25), there was no significant statistical difference between the two groups (p>0.05).Among the
CMV negative donors the mean Total WBC, Granulocyte, lymphocyte, middle cells (basophils, eosinophils
and monocytes), and platelet counts were higher than those of CMV positive donors, but there was also no
statistical difference between the two groups (p>0.05).
There were no abnormal alterations in the full blood count profile of cytomegalovirus antibody
positive prospective blood donors in Jos. Seropositive individuals can safely donate blood, provided there are
no other contraindications.




Key: Mean values =mean ± standard deviation (SD)
N=Sample size
MI cells=Eosinophils, Basophils, and Monocytes
Figure 1:
(Seropositivity= >0.5 iu/ml, OD=Optical density)
Knowledge of the haematological profile of
cytomegalovirus antibody positive persons is viewed
to be important by authors, as these individuals are
often accepted as donors for blood donation in many
countries, despite their positive viral serology/status.
The general view is that cytomegalovirus is a benign
opportunistic pathogen that is not likely to produce
clinical infection in the immunocompetent
hosts. This may be why some countries do not
routinely screen for Cytomegalovirus antibodies
prior to blood donation. While some have
recommended routine screening for CMV antibodies
among all prospective blood donors, other authors
suggested that screening for CMV should be included
only in the screening algorithm for potentially
susceptible recipients of blood and blood products.
Seroprevalence of CMV Antibody in Jos
Haematological Parameters of
Cytomegalovirus Positive and Negative Blood
Donors.
Standard (calibration curve) of serum








Age and Sex Distribution of Donors
The study was conducted at the blood bank of the Jos
University Teaching Hospital, (JUTH), Jos from
October 2006 to December 2006.Two hundred
prospective blood donors were recruited into the
study. They formed part of the general healthy
population. Their serum samples were taken and
analyzed for the presence of cytomegalovirus
an t ibod ies and ful l b lood counts . Al l
cytomegalovirus antibody tests were done using kits
manufactured by “Dialab” Austria (www.dialab.at)
.The kit is based on ELISA methodology. The
manufacturer's procedures were strictly followed.
Full blood counts were done using automated coulter
machine. With the aid of a questionnaire, relevant
personal, social and demographic information were
obtained from the donors. Ethical approval was
obtained from the research and ethical committee of
JUTH, Jos. Informed consent was obtained from all
the participants. The data were analyzed using Epi
info computer software version 3.3.2.Simple
proportion was used to determine the number of
donors positive for CMV. Means of haematological
parameters were cross tabulated against CMV status
to determine if there was any relationship.
Probability (p) values of <0.05 were taken as
significant.
A total of 200 prospective blood donors who
presented for bleeding were screened. The age range
for the study population was between 19 and 55
years, with a mean of 37 years. (Table 1). One
hundred and eighty four donors (92%) were positive
for CMV antibodies.
(Table 2,). Figure 1) show a standard (calibration)
curve, plotted to determine the CMV antibody status
of donors. Donors with antibody levels in excess of
0.5 iu/ml were regarded as seropositive. Table 3
showed statistical evaluations of the haematological
parameters and CMV status of donors: All
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Age (Years) Total Sex
Male Female
No Percent No Percent No Percent
15-19 3 1.5 3 100 0 0.0
20-24 40 20.0 39 97.5 1 2.5
25-29 58 29.0 57 98.3 1 1.7
30-34 37 18.5 37 100 0 0.0
35-39 33 16.5 33 100 0 0.0
40-44 17 8.5 15 88.2 2 11.8
45-49 8 4.0 8 100 0 0.0
50 And
Above 4 2.0 4 100 0 0.0
Total 200 100 196 98 4 2.0
Number of Subjects Percentage
CMV Negative 16 8





























Granulocytes (%) 50.3 4±6.02 54 .53±10 .49 P>0.05
Lymp hocytes (%) 37.7 ±10.38 41 .83±9.30
Mi Cells (% ) 7.48 ±5.24 7.85±5.21
Platelets(X109/L) 223.55±86.7 9 21 6.13±7 1.08
This study observed no statistically significant
difference in the haematological profile of CMV
seronegative and seropositive donors and noted all
values to be within the reference ranges for the
normal population. This is not entirely surprising, as
it is widely thought that haematological
complications and derangements are seen mostly in
the context of acute cytomegalovirus infections and
c y t om eg a l o v i ru s a s s oc i a t e d i n fe c t i o us
mononucleosis .Tsaparas et al also observed the
incidence of haematological complications
attributable to CMV to be more common among
immunocompromised patients who may suffer
anaemia, Neutropaenia,thrombocytopaenia,and
atypical lymphocytosis. The result of our study,
however, differs from similar studies in which other
viruses have been noted to produce a variety of
haematological complications and abnormalities
which may constitute a health hazard to an individual
intending to donate. The complication of
thrombocytopaenia attributable to a variety of viral
infections is well documented.
However, even though our study has shown a normal
full blood count profile of CMV seropositive
prospective blood donors, this does not by any means
suggest that there may be no other haematological
abnormalities in these individuals. Attention was
paid mainly to the quantitative blood cell counts
(PCV, WBC-total and differential and platelet
counts) by the authors probably because these are the
parameters that are more likely to disqualify an
individual who intends to donate. The authors are
aware that a few other parameters included under the
full blood count were not assessed in this study.
Qualitative blood cell assessment (blood film
morphology) readily comes to mind. While this is an
important component of the full blood count, the
authors feel blood film abnormalities may not be
sufficient enough to conclusively disqualify a
potential donor, or constitute a risk to blood
donation.
A variety of other haematologic alterations of viral
infections, but which may not necessarily pose a risk
to blood donation exist. It is suggested that further
studies with a larger sample size, and incorporating
more haematological indices might help in properly
evaluating, defining and characterizing the
haematological manifestations of cytomegalovirus.
In conclusion, this study has shown that
cytomegalovirus seropositive prospective blood
donors in Jos rarely present with abnormal full blood
count profile. Such persons are fit to donate blood,
and should be accepted for blood donation, provided
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